Ditto Bio
dittobio.com
Actively hiring
Health Care
Immunology & Inflammation Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Similar startupsby what they do, their industry and backers
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…
On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…
Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions.
ApogeeTherapeutics. Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe…
Precision therapy for autoimmune-driven diseases is now within reach. Current treatments for autoimmune diseases are non-specific, often…
Abivax is a clinical-stage biotechnology company driven to advance human health by regulating the immune response through the power of…
News
Mapping parasite molecules to treat autoimmune disease Ditto Bio
How we use parasite biology and our MoleculeMapper platform to improve target selection for autoimmune disease - including a viral molecule that invented the same mechanism as a blockbuster drug.
Read more
Report
Launch YC: Ditto Bio - Evolutionary therapies for autoimmune disease Y Combinator
We discover new drugs by harnessing parasite biology
Read more
Report